Loading...

We've got a brand new version of Simply Wall St! Try it out

Allergan

DB:A60
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
A60
DB
$51B
Market Cap
  1. Home
  2. DE
  3. Pharmaceuticals & Biotech
Company description

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The last earnings update was 8 days ago. More info.


Add to Portfolio Compare Print
  • Allergan has significant price volatility in the past 3 months.
A60 Share Price and Events
7 Day Returns
-0.7%
DB:A60
-0.4%
DE Pharmaceuticals
-3.8%
DE Market
1 Year Returns
-12.4%
DB:A60
-10.4%
DE Pharmaceuticals
-12%
DE Market
A60 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Allergan (A60) -0.7% -3.4% 12.8% -12.4% -36.6% -
DE Pharmaceuticals -0.4% 2.7% 4.9% -10.4% -22.3% 9.7%
DE Market -3.8% -7.2% -7.2% -12% -2.1% 5.9%
1 Year Return vs Industry and Market
  • A60 underperformed the Pharmaceuticals industry which returned -10.4% over the past year.
  • A60 matched the Germany Market (-12%) over the past year.
Price Volatility
A60
Industry
5yr Volatility vs Market

Value

 Is Allergan undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Allergan to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Allergan.

DB:A60 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 17 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.3%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:A60
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 7.1%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.7
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.701 (1 + (1- 12.5%) (45.32%))
0.986
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.99
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.986 * 7.14%)
7.27%

Discounted Cash Flow Calculation for DB:A60 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Allergan is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:A60 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.27%)
2020 6,326.60 Analyst x4 5,898.04
2021 6,363.73 Analyst x4 5,530.78
2022 6,405.13 Analyst x4 5,189.68
2023 6,520.98 Analyst x4 4,925.64
2024 6,569.98 Est @ 0.75% 4,626.49
2025 6,609.03 Est @ 0.59% 4,338.74
2026 6,641.06 Est @ 0.48% 4,064.43
2027 6,668.12 Est @ 0.41% 3,804.56
2028 6,691.71 Est @ 0.35% 3,559.38
2029 6,712.85 Est @ 0.32% 3,328.76
Present value of next 10 years cash flows $45,266.50
DB:A60 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $6,712.85 × (1 + 0.23%) ÷ (7.27% – 0.23%)
$95,596.33
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $95,596.33 ÷ (1 + 7.27%)10
$47,404.19
DB:A60 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $45,266.50 + $47,404.19
$92,670.69
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $92,670.69 / 328.03
$282.5
DB:A60 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:A60 represents 0.891x of NYSE:AGN
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.891x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 282.50 x 0.891
€251.71
Value per share (EUR) From above. €251.71
Current discount Discount to share price of €141.00
= -1 x (€141.00 - €251.71) / €251.71
44%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Allergan is available for.
Intrinsic value
44%
Share price is €141 vs Future cash flow value of €251.71
Current Discount Checks
For Allergan to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Allergan's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Allergan's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Allergan's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Allergan's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:A60 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-25.50
NYSE:AGN Share Price ** NYSE (2019-08-16) in USD $158.25
Germany Pharmaceuticals Industry PE Ratio Median Figure of 6 Publicly-Listed Pharmaceuticals Companies 26.49x
Germany Market PE Ratio Median Figure of 410 Publicly-Listed Companies 18.67x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Allergan.

DB:A60 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:AGN Share Price ÷ EPS (both in USD)

= 158.25 ÷ -25.50

-6.21x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allergan is loss making, we can't compare its value to the DE Pharmaceuticals industry average.
  • Allergan is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Allergan's expected growth come at a high price?
Raw Data
DB:A60 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.21x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts
98.2%per year
Germany Pharmaceuticals Industry PEG Ratio Median Figure of 5 Publicly-Listed Pharmaceuticals Companies 1.84x
Germany Market PEG Ratio Median Figure of 261 Publicly-Listed Companies 1.27x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Allergan, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Allergan's assets?
Raw Data
DB:A60 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $181.99
NYSE:AGN Share Price * NYSE (2019-08-16) in USD $158.25
Germany Pharmaceuticals Industry PB Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 2.27x
Germany Market PB Ratio Median Figure of 566 Publicly-Listed Companies 1.61x
DB:A60 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:AGN Share Price ÷ Book Value per Share (both in USD)

= 158.25 ÷ 181.99

0.87x

* Primary Listing of Allergan.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allergan is good value based on assets compared to the DE Pharmaceuticals industry average.
X
Value checks
We assess Allergan's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Allergan has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Allergan expected to perform in the next 1 to 3 years based on estimates from 17 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
98.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Allergan expected to grow at an attractive rate?
  • Allergan's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Allergan's earnings growth is expected to exceed the Germany market average.
  • Allergan's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:A60 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:A60 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts 98.2%
DB:A60 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 17 Analysts 2.1%
Germany Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 19%
Germany Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 3.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:A60 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:A60 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 16,790 6,766 9
2022-12-31 16,526 6,498 11
2021-12-31 16,106 6,343 1,750 15
2020-12-31 15,623 6,170 835 17
2019-12-31 15,510 5,299 -3,019 15
DB:A60 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 15,678 5,586 -8,505
2019-03-31 15,712 5,416 -7,218
2018-12-31 15,787 5,640 -5,143
2018-09-30 16,034 6,225 2,594
2018-06-30 16,157 6,254 -1,387
2018-03-31 16,040 6,814 -1,702
2017-12-31 15,941 6,079 -4,001
2017-09-30 15,479 3,906 -7,550
2017-06-30 15,067 1,336 -3,982
2017-03-31 14,744 916 -3,689
2016-12-31 14,571 1,446 -1,220
2016-09-30 14,313 3,091 -1,968

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Allergan's earnings are expected to grow significantly at over 20% yearly.
  • Allergan's revenue is expected to grow by 2.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:A60 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below

All data from Allergan Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:A60 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 8.37 8.37 8.37 1.00
2022-12-31 6.49 6.49 6.49 1.00
2021-12-31 3.95 5.63 2.27 2.00
2020-12-31 2.46 5.10 0.74 4.00
2019-12-31 -7.64 -2.12 -12.07 5.00
DB:A60 Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -25.50
2019-03-31 -21.46
2018-12-31 -15.26
2018-09-30 7.72
2018-06-30 -4.15
2018-03-31 -5.10
2017-12-31 -11.99
2017-09-30 -22.20
2017-06-30 -11.22
2017-03-31 -9.97
2016-12-31 -3.17
2016-09-30 -4.99

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Allergan is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Allergan's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Allergan has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Allergan performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Allergan's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Allergan does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Allergan's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Allergan's 1-year growth to the DE Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Allergan's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Allergan Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:A60 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 15,678.30 -8,504.80 4,406.00 1,997.00
2019-03-31 15,712.40 -7,218.30 4,380.00 2,216.20
2018-12-31 15,787.40 -5,142.80 4,331.20 2,253.40
2018-09-30 16,033.80 2,594.10 4,336.10 1,990.20
2018-06-30 16,156.70 -1,387.20 4,402.40 1,984.10
2018-03-31 16,039.90 -1,701.80 4,485.10 1,774.80
2017-12-31 15,940.70 -4,001.00 4,542.40 1,990.60
2017-09-30 15,478.90 -7,549.50 4,567.70 2,598.90
2017-06-30 15,066.80 -3,981.80 4,510.60 2,758.50
2017-03-31 14,744.20 -3,688.70 4,354.90 2,886.30
2016-12-31 14,570.60 -1,219.50 4,092.20 2,568.50
2016-09-30 14,313.20 -1,967.80 4,256.60 1,954.10
2016-06-30 14,160.50 -2,462.30 4,085.50 2,517.20
2016-03-31 14,104.40 -2,511.30 3,933.00 2,256.70
2015-12-31 12,688.10 -3,177.80 3,673.30 2,067.20
2015-09-30 11,496.80 -3,303.20 3,176.70 1,972.10
2015-06-30 10,178.10 -3,519.30 2,963.90 963.10
2015-03-31 6,066.80 -3,332.60 2,031.50 584.00
2014-12-31 4,676.50 -2,484.60 1,832.90 583.80
2014-09-30 7,102.60 -1,570.30 1,754.70 441.10
2014-06-30 6,964.80 -342.60 1,585.00 453.40
2014-03-31 9,437.20 -551.10 2,013.90 644.60
2013-12-31 2,602.50 -467.50 827.70 190.20
2013-09-30 7,648.50 -574.00 1,655.20 544.90
2013-06-30 6,920.70 -562.90 1,392.10 493.70
2013-03-31 6,286.10 -60.30 1,223.80 437.10
2012-12-31 5,914.90 97.30 1,171.80 402.50
2012-09-30 5,709.30 164.10 953.50 343.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Allergan has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Allergan has efficiently used its assets last year compared to the DE Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Allergan improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Allergan's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Allergan has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Allergan's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Allergan's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Allergan is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Allergan's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Allergan's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Allergan Company Filings, last reported 1 month ago.

DB:A60 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 59,696.10 22,703.50 1,973.70
2019-03-31 61,559.60 23,525.90 1,783.70
2018-12-31 65,131.00 23,790.10 1,907.30
2018-09-30 70,520.90 23,575.50 1,209.90
2018-06-30 71,264.00 25,341.10 1,696.20
2018-03-31 72,346.00 26,562.60 2,032.20
2017-12-31 73,837.10 30,072.60 6,449.30
2017-09-30 71,173.50 30,333.40 5,441.80
2017-06-30 75,232.80 30,235.70 5,825.90
2017-03-31 75,198.80 31,747.00 8,951.10
2016-12-31 76,200.50 32,766.30 13,225.50
2016-09-30 89,730.40 32,770.00 27,392.30
2016-06-30 76,640.80 39,581.70 506.60
2016-03-31 77,448.70 42,567.50 2,273.80
2015-12-31 76,589.30 42,530.40 1,105.30
2015-09-30 77,480.10 42,683.50 2,070.90
2015-06-30 72,074.50 42,870.30 1,526.40
2015-03-31 71,409.50 44,324.60 2,130.90
2014-12-31 28,335.50 15,531.10 251.00
2014-09-30 29,145.00 15,537.10 340.40
2014-06-30 9,684.70 12,331.40 4,296.10
2014-03-31 9,628.60 8,720.50 340.20
2013-12-31 9,537.10 9,052.00 331.50
2013-09-30 3,748.00 6,310.40 373.50
2013-06-30 3,541.00 6,351.10 234.90
2013-03-31 3,622.30 6,421.50 337.40
2012-12-31 3,856.40 6,433.30 328.00
2012-09-30 3,689.90 1,220.60 234.40
  • Allergan's level of debt (38%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (125% vs 38% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Allergan has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Allergan has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -35.5% per year.
X
Financial health checks
We assess Allergan's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Allergan has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Allergan's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.87%
Current annual income from Allergan dividends. Estimated to be 1.97% next year.
If you bought €2,000 of Allergan shares you are expected to receive €37 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Allergan's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.61%).
  • Allergan's dividend is below the markets top 25% of dividend payers in Germany (4.29%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:A60 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
Germany Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 3%
Germany Market Average Dividend Yield Market Cap Weighted Average of 320 Stocks 3.4%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 4.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:A60 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 3.30 1.00
2022-12-31 3.40 2.00
2021-12-31 3.22 5.00
2020-12-31 3.07 7.00
2019-12-31 2.96 5.00
DB:A60 Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-07-19 2.960 1.848
2019-05-03 2.960 2.104
2019-01-25 2.960 2.059
2018-10-26 2.880 1.897
2018-07-30 2.880 1.536
2018-05-03 2.880 1.753
2017-10-27 2.880 1.722
2017-08-02 2.800 1.306
2017-05-05 2.800 1.179
2017-02-03 2.800 1.163
2016-11-04 2.800 1.377
2016-11-02 2.800 1.445

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Allergan has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Allergan only paid a dividend in the past 3 years.
Current Payout to shareholders
What portion of Allergan's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (5.5x coverage).
X
Income/ dividend checks
We assess Allergan's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Allergan afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Allergan has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Allergan's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Brent Saunders
COMPENSATION $6,624,473
AGE 49
TENURE AS CEO 5.1 years
CEO Bio

Mr. Brenton L. Saunders, also known as Brent, J.D., has been the Chairman of the Board at Allergan plc since October 26, 2016 and also has been its Chief Executive Officer and President since July 1, 2014. Mr. Saunders serves as the Chief Executive Officer and President of Actavis Ltd. (Alternate Name: Actavis Plc). He has significant healthcare industry expertise and led various business transformations and integrations. He has an extensive experience negotiating and implementing corporate integrity agreements with state and federal agencies. He has extensive knowledge of compliance, risk assessment, strategy and business development and extensive experience as an Officer and Director of Public Companies in the healthcare and pharmaceuticals industry. He served as the Chief Executive Officer and President of Forest Laboratories, LLC from October 1, 2013 to 2014. He served as Senior Vice President of Compliance, Legal and Regulatory at HomeCare America. He served as the Chief Executive Officer of Bausch & Lomb Incorporated from March 15, 2010 to August 2013. He served as a Special Adviser of General Atlantic LLC. He served as the President of Bausch & Lomb Holdings Incorporated from 2010 to February 2013 and also served as its Chief Executive Officer since March 15, 2010. He served as Senior Executive of Schering-Plough from 2003 to 2010 and served as its President of Global Consumer Health Care. He served as the Head of Integration for both Schering-Plough's merger with Merck & Co., Inc. He served as the President of Consumer Health Care and Senior Vice President of Schering-Plough Corporation since February 2007. He was responsible for leading the U.S. and Canadian Consumer Health Care business and works collaboratively with the Global Pharmaceutical Business unit. He served as Senior Vice President of Global Compliance and Business Practices of Schering-Plough Corporation from November 1, 2003 to February 20, 2007. He served as a Member of Executive Management Team (EMT) and Member of Operations Management Team (OMT) at Schering-Plough Corporation. His responsibilities included the development of Global Standards, Training and Enforcement Programs for Compliance in all areas of Schering Plough Corp., including manufacturing, R&D programs, clinical trials and sales and marketing. He was also responsible for the implementation of privacy policies for customers, patients, employees and other stakeholders. He joined Schering-Plough from PricewaterhouseCoopers, where he led its compliance business advisory services group. He was a Partner and Head of the Compliance Business Advisory Group at PricewaterhouseCoopers LLP from 2000 to 2003. He served as the Chief Compliance Officer of Coventry Health Care Inc. and also served as its Chief Risk Officer from 1998 to 1999. He began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. He co-founded and served as the President of the Health Care Compliance Association. He served as Senior Vice President of Compliance, Legal and Regulatory at Home Care Corporation of America. He served as Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers Malta. He co-founded Health Care Compliance Association in 1995. He has been an Independent Director of Cisco Systems, Inc. since March 13, 2017. He has been a Director of Allergan plc since July 1, 2014. He serves on the Boards of the Overlook Hospital Foundation and Actavis Funding SCS. He served as a Member of Upstate New York Regional Advisory Board at The Federal Reserve Bank of New York since June 9, 2010. He served as a Director of Forest Laboratories, LLC since August 2011. He is a natural innovator and leader with a deep understanding of business transformation. He served as a Director of Bausch & Lomb Holdings Incorporated and Bausch & Lomb Incorporated since March 15, 2010. He served as a Director of electroCore LLC. He serves as a Trustee of University of Pittsburgh. He also serves on the transition team for New Jersey Governor-Elect Chris Christie. He serves as a Member of the Business Council and PhRMA. He serves on the Board of Directors at RWJBarnabas Health. He served as the Chairman of the New York chapter of the American Heart Association. He is a noted speaker on compliance and risk management issues in the health care industry and also taught health law at Widener School of Law as an Adjunct Faculty Member. In 1997, he was named Compliance Officer of the Year at Health Care Compliance Association. Mr. Saunders has a JD from the Temple University School of Law, an MBA from the Temple University School of Business and Management and graduated with a BA in Economics from the University of Pittsburgh.

CEO Compensation
  • Brent's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Brent's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Allergan management team in years:

5
Average Tenure
51
Average Age
  • The average tenure for the Allergan management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Brent Saunders

TITLE
Chairman
COMPENSATION
$7M
AGE
49
TENURE
5.1 yrs

Matt Walsh

TITLE
Executive VP & CFO
COMPENSATION
$11M
AGE
52
TENURE
1.5 yrs

Bob Bailey

TITLE
Executive VP
COMPENSATION
$3M
AGE
56
TENURE
5.1 yrs

Bill Meury

TITLE
Executive VP & Chief Commercial Officer
COMPENSATION
$4M
AGE
51
TENURE
5.1 yrs

C. Nicholson

TITLE
Executive VP and Chief R&D Officer
COMPENSATION
$3M
AGE
64
TENURE
5 yrs

Wayne Swanton

TITLE
Executive Vice President of Global Operations
AGE
51
TENURE
1.7 yrs

James D'Arecca

TITLE
Chief Accounting Officer
AGE
48
TENURE
6 yrs

Manisha Narasimhan

TITLE
Vice President of Investor Relations & Strategic Initiatives
TENURE
0.7 yrs

Alex Kelly

TITLE
Executive VP & Chief Communications Officer
TENURE
4.3 yrs

Brent Hauser

TITLE
Vice President of Sales & Marketing
AGE
42
Board of Directors Tenure

Average tenure and age of the Allergan board of directors in years:

2.7
Average Tenure
63.5
Average Age
  • The average tenure for the Allergan board of directors is less than 3 years, this suggests a new board.
Board of Directors

Brent Saunders

TITLE
Chairman
COMPENSATION
$7M
AGE
49
TENURE
2.8 yrs

Chris Bodine

TITLE
Independent Director
COMPENSATION
$474K
AGE
63
TENURE
10.2 yrs

John Davidson

TITLE
Independent Director
COMPENSATION
$450K
AGE
64
TENURE
1.3 yrs

Tom Freyman

TITLE
Independent Director
COMPENSATION
$398K
AGE
65
TENURE
1.2 yrs

Chris Coughlin

TITLE
Lead Independent Director
COMPENSATION
$500K
AGE
67
TENURE
2.8 yrs

Nesli Basgoz

TITLE
Independent Director
COMPENSATION
$474K
AGE
61
TENURE
5.1 yrs

Peter McDonnell

TITLE
Independent Director
COMPENSATION
$450K
AGE
60
TENURE
4.4 yrs

Adriane Brown

TITLE
Independent Director
COMPENSATION
$450K
AGE
61
TENURE
2.5 yrs

Joe Boccuzi

TITLE
Independent Director
COMPENSATION
$450K
AGE
72
TENURE
2.6 yrs

Michael Greenberg

TITLE
Director
COMPENSATION
$331K
AGE
64
TENURE
1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
12. Aug 19 Sell GIC Pte. Ltd. Company 09. Aug 19 09. Aug 19 -31,152 €143.02 €-4,455,463
12. Aug 19 Sell Franklin Resources, Inc. Company 09. Aug 19 09. Aug 19 -455 €142.95 €-64,932
12. Aug 19 Buy Franklin Resources, Inc. Company 09. Aug 19 09. Aug 19 8 €142.50 €1,140
12. Aug 19 Sell Northern Trust Global Investments Company 09. Aug 19 09. Aug 19 -1,402 €142.50 €-199,781
12. Aug 19 Buy Northern Trust Global Investments Company 09. Aug 19 09. Aug 19 2,878 €142.50 €410,107
12. Aug 19 Sell Legg Mason, Inc. Company 09. Aug 19 09. Aug 19 -400 €141.90 €-56,760
12. Aug 19 Sell D. E. Shaw & Co., L.P. Company 09. Aug 19 09. Aug 19 -62,657 €143.66 €-9,001,073
12. Aug 19 Buy D. E. Shaw & Co., L.P. Company 09. Aug 19 09. Aug 19 7,700 €143.36 €1,103,888
12. Aug 19 Sell T. Rowe Price Group, Inc. Company 09. Aug 19 09. Aug 19 -281 €142.50 €-40,015
12. Aug 19 Buy T. Rowe Price Group, Inc. Company 09. Aug 19 09. Aug 19 99 €141.75 €14,033
09. Aug 19 Sell T. Rowe Price Group, Inc. Company 08. Aug 19 08. Aug 19 -677 €142.86 €-96,716
09. Aug 19 Buy T. Rowe Price Group, Inc. Company 08. Aug 19 08. Aug 19 90 €142.14 €12,793
12. Aug 19 Sell Citadel Advisors, LLC Company 09. Aug 19 09. Aug 19 -37,183 €143.71 €-5,343,561
12. Aug 19 Buy Citadel Advisors, LLC Company 09. Aug 19 09. Aug 19 35,395 €143.67 €5,085,346
12. Aug 19 Sell BlackRock, Inc. Company 09. Aug 19 09. Aug 19 -10,332 €142.50 €-1,472,215
12. Aug 19 Buy BlackRock, Inc. Company 09. Aug 19 09. Aug 19 7,295 €142.50 €1,039,413
12. Aug 19 Sell Wellington Management Group LLP Company 09. Aug 19 09. Aug 19 -176,828 €142.50 €-25,114,378
12. Aug 19 Buy Wellington Management Group LLP Company 09. Aug 19 09. Aug 19 9,249 €142.50 €1,313,518
09. Aug 19 Sell Wellington Management Group LLP Company 08. Aug 19 08. Aug 19 -735,360 €142.57 €-104,722,401
09. Aug 19 Buy Wellington Management Group LLP Company 08. Aug 19 08. Aug 19 15,941 €142.57 €2,270,220
12. Aug 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 09. Aug 19 09. Aug 19 -57,580 €143.42 €-8,257,871
09. Aug 19 Sell Franklin Resources, Inc. Company 08. Aug 19 08. Aug 19 -1,500 €142.61 €-213,909
09. Aug 19 Sell Northern Trust Global Investments Company 08. Aug 19 08. Aug 19 -1,051 €142.80 €-150,083
09. Aug 19 Buy Northern Trust Global Investments Company 08. Aug 19 08. Aug 19 19,091 €142.81 €2,726,405
09. Aug 19 Sell GIC Pte. Ltd. Company 08. Aug 19 08. Aug 19 -249,352 €142.78 €-35,593,955
09. Aug 19 Buy GIC Pte. Ltd. Company 08. Aug 19 08. Aug 19 20,000 €142.57 €2,851,404
09. Aug 19 Sell FMR LLC Company 08. Aug 19 08. Aug 19 -102,257 €142.73 €-14,577,728
09. Aug 19 Buy FMR LLC Company 08. Aug 19 08. Aug 19 4,689 €142.35 €667,466
09. Aug 19 Sell Legg Mason, Inc. Company 08. Aug 19 08. Aug 19 -51 €142.16 €-7,250
09. Aug 19 Buy Legg Mason, Inc. Company 08. Aug 19 08. Aug 19 26 €142.42 €3,703
09. Aug 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 08. Aug 19 08. Aug 19 152,577 €143.01 €21,819,617
09. Aug 19 Sell BlackRock, Inc. Company 08. Aug 19 08. Aug 19 -363 €142.57 €-51,753
09. Aug 19 Buy BlackRock, Inc. Company 08. Aug 19 08. Aug 19 5,952 €142.59 €848,586
09. Aug 19 Sell Citadel Advisors, LLC Company 08. Aug 19 08. Aug 19 -30,117 €142.99 €-4,306,412
09. Aug 19 Buy Citadel Advisors, LLC Company 08. Aug 19 08. Aug 19 34,240 €143.01 €4,896,568
08. Aug 19 Sell FMR LLC Company 07. Aug 19 07. Aug 19 -47,335 €142.27 €-6,703,170
08. Aug 19 Buy FMR LLC Company 07. Aug 19 07. Aug 19 3,818 €142.14 €542,235
08. Aug 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 30. Jul 19 30. Jul 19 135,013 €145.05 €19,583,679
08. Aug 19 Sell Northern Trust Global Investments Company 07. Aug 19 07. Aug 19 -441 €141.84 €-62,551
08. Aug 19 Buy Northern Trust Global Investments Company 07. Aug 19 07. Aug 19 2,332 €141.87 €330,830
08. Aug 19 Sell Citadel Advisors, LLC Company 07. Aug 19 07. Aug 19 -2,111,610 €142.37 €-300,636,546
08. Aug 19 Buy Citadel Advisors, LLC Company 07. Aug 19 07. Aug 19 51,780 €142.37 €7,372,081
08. Aug 19 Sell Legg Mason, Inc. Company 07. Aug 19 07. Aug 19 -52 €141.97 €-7,383
08. Aug 19 Buy Legg Mason, Inc. Company 07. Aug 19 07. Aug 19 20 €142.18 €2,844
08. Aug 19 Sell BlackRock, Inc. Company 07. Aug 19 07. Aug 19 -23,924 €142.35 €-3,403,580
08. Aug 19 Buy BlackRock, Inc. Company 07. Aug 19 07. Aug 19 623 €141.76 €88,287
08. Aug 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 07. Aug 19 07. Aug 19 -399,489 €142.48 €-56,919,193
08. Aug 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 07. Aug 19 07. Aug 19 239,894 €142.48 €34,180,097
08. Aug 19 Sell GIC Pte. Ltd. Company 07. Aug 19 07. Aug 19 -13,376 €142.48 €-1,905,812
08. Aug 19 Buy GIC Pte. Ltd. Company 07. Aug 19 07. Aug 19 67,100 €141.45 €9,491,095
08. Aug 19 Sell Wellington Management Group LLP Company 07. Aug 19 07. Aug 19 -705,630 €142.03 €-100,039,519
08. Aug 19 Buy Wellington Management Group LLP Company 07. Aug 19 07. Aug 19 8,240 €142.03 €1,170,293
08. Aug 19 Sell Longview Partners (Guernsey) Ltd Company 07. Aug 19 07. Aug 19 -6,600 €141.45 €-933,550
07. Aug 19 Sell GIC Pte. Ltd. Company 06. Aug 19 06. Aug 19 -342,110 €143.93 €-48,953,851
07. Aug 19 Buy GIC Pte. Ltd. Company 06. Aug 19 06. Aug 19 110,505 €142.46 €15,742,152
07. Aug 19 Sell FMR LLC Company 06. Aug 19 06. Aug 19 -59,050 €143.81 €-8,410,728
07. Aug 19 Buy FMR LLC Company 06. Aug 19 06. Aug 19 9,007 €143.87 €1,291,025
07. Aug 19 Sell Wellington Management Group LLP Company 06. Aug 19 06. Aug 19 -73,198 €143.93 €-10,522,256
07. Aug 19 Buy Wellington Management Group LLP Company 06. Aug 19 06. Aug 19 83,808 €143.65 €12,031,293
06. Aug 19 Buy GIC Pte. Ltd. Company 05. Aug 19 05. Aug 19 130,744 €143.57 €18,771,059
07. Aug 19 Sell BlackRock, Inc. Company 06. Aug 19 06. Aug 19 -5,363 €143.47 €-764,521
07. Aug 19 Buy BlackRock, Inc. Company 06. Aug 19 06. Aug 19 8,785 €142.84 €1,254,432
07. Aug 19 Sell Citadel Advisors, LLC Company 06. Aug 19 06. Aug 19 -13,834 €144.01 €-1,992,243
07. Aug 19 Buy Citadel Advisors, LLC Company 06. Aug 19 06. Aug 19 13,411 €144.06 €1,932,045
07. Aug 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 06. Aug 19 06. Aug 19 -88,419 €150.19 €-13,279,481
07. Aug 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 06. Aug 19 06. Aug 19 63,145 €144.03 €9,094,680
07. Aug 19 Sell Legg Mason, Inc. Company 06. Aug 19 06. Aug 19 -88 €142.47 €-12,538
07. Aug 19 Buy Legg Mason, Inc. Company 06. Aug 19 06. Aug 19 211 €142.75 €30,121
05. Aug 19 Sell T. Rowe Price Group, Inc. Company 02. Aug 19 02. Aug 19 -2 €144.89 €-290
05. Aug 19 Buy T. Rowe Price Group, Inc. Company 02. Aug 19 02. Aug 19 4 €145.15 €581
02. Aug 19 Sell T. Rowe Price Group, Inc. Company 01. Aug 19 01. Aug 19 -817 €145.43 €-118,793
02. Aug 19 Buy T. Rowe Price Group, Inc. Company 01. Aug 19 01. Aug 19 100 €144.90 €14,490
07. Aug 19 Sell Longview Partners (Guernsey) Ltd Company 06. Aug 19 06. Aug 19 -20,520 €142.99 €-2,934,204
05. Aug 19 Sell BlackRock, Inc. Company 02. Aug 19 02. Aug 19 -7,621 €144.97 €-1,104,788
05. Aug 19 Buy BlackRock, Inc. Company 02. Aug 19 02. Aug 19 15,167 €145.26 €2,198,844
05. Aug 19 Sell Citadel Advisors, LLC Company 02. Aug 19 02. Aug 19 -56,584 €145.34 €-8,224,169
05. Aug 19 Buy Citadel Advisors, LLC Company 02. Aug 19 02. Aug 19 49,958 €150.57 €7,521,985
05. Aug 19 Sell FMR LLC Company 02. Aug 19 02. Aug 19 -1,715 €145.06 €-248,771
05. Aug 19 Buy FMR LLC Company 02. Aug 19 02. Aug 19 2,132 €145.04 €309,222
02. Aug 19 Sell FMR LLC Company 01. Aug 19 01. Aug 19 -4,695 €145.67 €-681,908
02. Aug 19 Buy FMR LLC Company 01. Aug 19 01. Aug 19 4,680 €145.37 €680,318
06. Aug 19 Sell Franklin Resources, Inc. Company 05. Aug 19 05. Aug 19 -1 €143.57 €-144
06. Aug 19 Buy Franklin Resources, Inc. Company 05. Aug 19 05. Aug 19 5 €143.61 €718
06. Aug 19 Sell FMR LLC Company 05. Aug 19 05. Aug 19 -25,402 €143.53 €-3,638,584
06. Aug 19 Buy FMR LLC Company 05. Aug 19 05. Aug 19 10,982 €143.73 €1,574,536
06. Aug 19 Sell Wellington Management Group LLP Company 05. Aug 19 05. Aug 19 -40,756 €143.54 €-5,834,829
06. Aug 19 Buy Wellington Management Group LLP Company 05. Aug 19 05. Aug 19 351 €143.60 €50,259
06. Aug 19 Sell Northern Trust Global Investments Company 05. Aug 19 05. Aug 19 -726 €143.66 €-104,298
06. Aug 19 Buy Northern Trust Global Investments Company 05. Aug 19 05. Aug 19 2,836 €143.67 €407,446
06. Aug 19 Sell BlackRock, Inc. Company 05. Aug 19 05. Aug 19 -4,924 €143.57 €-706,371
06. Aug 19 Buy BlackRock, Inc. Company 05. Aug 19 05. Aug 19 346 €143.57 €49,676
06. Aug 19 Sell Legg Mason, Inc. Company 05. Aug 19 05. Aug 19 -11 €143.27 €-1,576
06. Aug 19 Buy Legg Mason, Inc. Company 05. Aug 19 05. Aug 19 5 €143.12 €716
02. Aug 19 Sell Legg Mason, Inc. Company 01. Aug 19 01. Aug 19 -1,509 €145.41 €-219,427
02. Aug 19 Buy Legg Mason, Inc. Company 01. Aug 19 01. Aug 19 2 €145.77 €292
05. Aug 19 Sell Northern Trust Global Investments Company 02. Aug 19 02. Aug 19 -742 €144.97 €-107,565
05. Aug 19 Buy Northern Trust Global Investments Company 02. Aug 19 02. Aug 19 1,649 €145.11 €239,287
05. Aug 19 Sell Franklin Resources, Inc. Company 02. Aug 19 02. Aug 19 -18 €144.97 €-2,609
05. Aug 19 Buy Franklin Resources, Inc. Company 02. Aug 19 02. Aug 19 10 €145.14 €1,451
05. Aug 19 Sell Northern Trust Global Investments Company 01. Aug 19 01. Aug 19 -3,241 €146.45 €-474,650
05. Aug 19 Buy Northern Trust Global Investments Company 01. Aug 19 01. Aug 19 2,366 €146.36 €346,291
05. Aug 19 Sell Wellington Management Group LLP Company 02. Aug 19 02. Aug 19 -47,122 €145.02 €-6,833,654
05. Aug 19 Buy Wellington Management Group LLP Company 02. Aug 19 02. Aug 19 13,829 €144.99 €2,005,008
02. Aug 19 Sell Wellington Management Group LLP Company 01. Aug 19 01. Aug 19 -482,480 €145.64 €-70,244,845
02. Aug 19 Buy Wellington Management Group LLP Company 01. Aug 19 01. Aug 19 94 €144.97 €13,627
02. Aug 19 Buy Franklin Resources, Inc. Company 01. Aug 19 01. Aug 19 57,515 €145.85 €8,373,274
05. Aug 19 Sell Legg Mason, Inc. Company 02. Aug 19 02. Aug 19 -73 €145.06 €-10,589
05. Aug 19 Buy Legg Mason, Inc. Company 02. Aug 19 02. Aug 19 74 €145.11 €10,738
02. Aug 19 Sell Citadel Advisors, LLC Company 01. Aug 19 01. Aug 19 -38,851 €146.48 €-5,690,850
02. Aug 19 Buy Citadel Advisors, LLC Company 01. Aug 19 01. Aug 19 40,253 €146.57 €5,899,852
02. Aug 19 Sell BlackRock, Inc. Company 01. Aug 19 01. Aug 19 -5,789 €145.43 €-841,897
02. Aug 19 Buy BlackRock, Inc. Company 01. Aug 19 01. Aug 19 3,257 €146.06 €474,197
01. Aug 19 Sell FMR LLC Company 31. Jul 19 31. Jul 19 -32,071 €144.78 €-4,640,532
01. Aug 19 Buy FMR LLC Company 31. Jul 19 31. Jul 19 1,636 €144.65 €236,647
01. Aug 19 Sell Legg Mason, Inc. Company 31. Jul 19 31. Jul 19 -157 €144.11 €-22,625
01. Aug 19 Buy Legg Mason, Inc. Company 31. Jul 19 31. Jul 19 31 €144.12 €4,468
01. Aug 19 Sell BlackRock, Inc. Company 31. Jul 19 31. Jul 19 -26,289 €144.71 €-3,793,719
01. Aug 19 Buy BlackRock, Inc. Company 31. Jul 19 31. Jul 19 12,396 €144.73 €1,788,331
01. Aug 19 Sell Citadel Advisors, LLC Company 31. Jul 19 31. Jul 19 -55,721 €144.86 €-8,071,531
01. Aug 19 Buy Citadel Advisors, LLC Company 31. Jul 19 31. Jul 19 48,987 €144.84 €7,095,189
31. Jul 19 Buy T. Rowe Price Group, Inc. Company 30. Jul 19 30. Jul 19 27,336 €144.64 €3,953,097
01. Aug 19 Buy Franklin Resources, Inc. Company 31. Jul 19 31. Jul 19 105,000 €144.54 €15,176,878
01. Aug 19 Sell Wellington Management Group LLP Company 31. Jul 19 31. Jul 19 -1,035,639 €144.57 €-149,694,075
01. Aug 19 Buy Wellington Management Group LLP Company 31. Jul 19 31. Jul 19 133 €144.69 €19,243
30. Jul 19 Sell Longview Partners (Guernsey) Ltd Company 29. Jul 19 29. Jul 19 -5,000 €144.57 €-722,836
01. Aug 19 Buy GIC Pte. Ltd. Company 31. Jul 19 31. Jul 19 4,165 €144.21 €600,632
30. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 29. Jul 19 29. Jul 19 -259,583 €145.35 €-37,730,001
30. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 29. Jul 19 29. Jul 19 201,653 €145.17 €29,273,741
31. Jul 19 Sell Franklin Resources, Inc. Company 30. Jul 19 30. Jul 19 -6,503 €144.46 €-939,411
31. Jul 19 Buy BlackRock, Inc. Company 30. Jul 19 30. Jul 19 4,983 €144.73 €719,648
31. Jul 19 Sell Northern Trust Global Investments Company 30. Jul 19 30. Jul 19 -5,801 €144.85 €-840,292
31. Jul 19 Buy Northern Trust Global Investments Company 30. Jul 19 30. Jul 19 11,163 €144.70 €1,615,248
31. Jul 19 Sell FMR LLC Company 30. Jul 19 30. Jul 19 -2,206 €144.87 €-318,938
31. Jul 19 Buy FMR LLC Company 30. Jul 19 30. Jul 19 1,823 €144.81 €263,985
31. Jul 19 Sell Citadel Advisors, LLC Company 30. Jul 19 30. Jul 19 -51,354 €145.04 €-7,448,454
31. Jul 19 Buy Citadel Advisors, LLC Company 30. Jul 19 30. Jul 19 57,120 €145.03 €8,284,250
31. Jul 19 Sell Legg Mason, Inc. Company 30. Jul 19 30. Jul 19 -23 €144.57 €-3,325
31. Jul 19 Buy Legg Mason, Inc. Company 30. Jul 19 30. Jul 19 98 €144.63 €14,174
31. Jul 19 Sell Wellington Management Group LLP Company 30. Jul 19 30. Jul 19 -1,530,304 €144.56 €-221,164,854
31. Jul 19 Buy Wellington Management Group LLP Company 30. Jul 19 30. Jul 19 15,366 €144.51 €2,220,541
31. Jul 19 Sell Longview Partners (Guernsey) Ltd Company 30. Jul 19 30. Jul 19 -900 €144.33 €-129,899
31. Jul 19 Buy Longview Partners (Guernsey) Ltd Company 30. Jul 19 30. Jul 19 2,800 €144.33 €404,131
30. Jul 19 Sell T. Rowe Price Group, Inc. Company 29. Jul 19 29. Jul 19 -3,893 €144.57 €-562,800
30. Jul 19 Sell FMR LLC Company 29. Jul 19 29. Jul 19 -2,239 €144.76 €-324,108
30. Jul 19 Buy FMR LLC Company 29. Jul 19 29. Jul 19 2,878 €144.79 €416,710
30. Jul 19 Sell Citadel Advisors, LLC Company 29. Jul 19 29. Jul 19 -70,763 €145.59 €-10,302,138
30. Jul 19 Buy Citadel Advisors, LLC Company 29. Jul 19 29. Jul 19 67,874 €145.26 €9,859,289
30. Jul 19 Sell Legg Mason, Inc. Company 29. Jul 19 29. Jul 19 -20 €144.69 €-2,894
30. Jul 19 Buy Legg Mason, Inc. Company 29. Jul 19 29. Jul 19 507 €144.76 €73,391
30. Jul 19 Sell BlackRock, Inc. Company 29. Jul 19 29. Jul 19 -7,273 €144.57 €-1,051,437
30. Jul 19 Buy BlackRock, Inc. Company 29. Jul 19 29. Jul 19 3,598 €145.03 €520,252
30. Jul 19 Buy Franklin Resources, Inc. Company 29. Jul 19 29. Jul 19 70 €144.87 €10,141
30. Jul 19 Sell Northern Trust Global Investments Company 29. Jul 19 29. Jul 19 -734 €145.07 €-106,481
30. Jul 19 Buy Northern Trust Global Investments Company 29. Jul 19 29. Jul 19 14,532 €145.18 €2,109,803
30. Jul 19 Sell Wellington Management Group LLP Company 29. Jul 19 29. Jul 19 -900,812 €144.78 €-130,419,960
29. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 25. Jul 19 25. Jul 19 -329,136 €148.59 €-48,904,889
29. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 25. Jul 19 25. Jul 19 306,074 €144.33 €44,176,582
29. Jul 19 Buy Adage Capital Management, L.P. Company 26. Jul 19 26. Jul 19 1,250,000 €145.38 €181,595,199
29. Jul 19 Sell BlackRock, Inc. Company 26. Jul 19 26. Jul 19 -1,235 €145.05 €-178,816
29. Jul 19 Buy BlackRock, Inc. Company 26. Jul 19 26. Jul 19 1,860 €144.77 €269,271
29. Jul 19 Sell FMR LLC Company 26. Jul 19 26. Jul 19 -1,386 €144.90 €-200,810
29. Jul 19 Buy FMR LLC Company 26. Jul 19 26. Jul 19 8,063 €145.45 €1,169,654
29. Jul 19 Sell Legg Mason, Inc. Company 26. Jul 19 26. Jul 19 -17 €145.38 €-2,471
29. Jul 19 Buy Legg Mason, Inc. Company 26. Jul 19 26. Jul 19 35 €145.13 €5,080
29. Jul 19 Sell Northern Trust Global Investments Company 26. Jul 19 26. Jul 19 -1,202 €145.35 €-174,517
29. Jul 19 Buy Northern Trust Global Investments Company 26. Jul 19 26. Jul 19 1,456 €145.44 €211,277
29. Jul 19 Sell Franklin Resources, Inc. Company 26. Jul 19 26. Jul 19 -12,513 €145.48 €-1,820,307
29. Jul 19 Sell Citadel Advisors, LLC Company 26. Jul 19 26. Jul 19 -143,675 €145.61 €-20,921,186
29. Jul 19 Buy Citadel Advisors, LLC Company 26. Jul 19 26. Jul 19 144,582 €145.59 €21,049,358
29. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 26. Jul 19 26. Jul 19 -22,792 €145.64 €-3,319,464
29. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 26. Jul 19 26. Jul 19 58,082 €145.43 €8,446,621
26. Jul 19 Sell Northern Trust Global Investments Company 25. Jul 19 25. Jul 19 -839 €143.44 €-120,343
26. Jul 19 Buy Northern Trust Global Investments Company 25. Jul 19 25. Jul 19 6,718 €144.13 €968,251
26. Jul 19 Sell FMR LLC Company 25. Jul 19 25. Jul 19 -16 €144.18 €-2,302
26. Jul 19 Buy FMR LLC Company 25. Jul 19 25. Jul 19 3,702 €143.37 €530,771
26. Jul 19 Sell Legg Mason, Inc. Company 25. Jul 19 25. Jul 19 -132 €143.23 €-18,906
26. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 24. Jul 19 24. Jul 19 -811,013 €145.30 €-117,837,168
26. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 24. Jul 19 24. Jul 19 1,383,068 €145.29 €200,942,215
26. Jul 19 Sell The Baupost Group, LLC Company 24. Jul 19 24. Jul 19 -543,092 €145.06 €-78,692,252
26. Jul 19 Sell T. Rowe Price Group, Inc. Company 25. Jul 19 25. Jul 19 -2,820 €143.44 €-404,492
26. Jul 19 Buy T. Rowe Price Group, Inc. Company 25. Jul 19 25. Jul 19 20,911 €143.41 €2,998,845
26. Jul 19 Sell BlackRock, Inc. Company 25. Jul 19 25. Jul 19 -1,208 €143.44 €-173,272
26. Jul 19 Buy BlackRock, Inc. Company 25. Jul 19 25. Jul 19 8,270 €144.26 €1,186,886
26. Jul 19 Sell Citadel Advisors, LLC Company 25. Jul 19 25. Jul 19 -27,863 €144.30 €-4,020,552
26. Jul 19 Buy Citadel Advisors, LLC Company 25. Jul 19 25. Jul 19 28,227 €144.69 €4,084,207
26. Jul 19 Sell Franklin Resources, Inc. Company 25. Jul 19 25. Jul 19 -33,600 €143.32 €-4,815,562
26. Jul 19 Buy Franklin Resources, Inc. Company 25. Jul 19 25. Jul 19 770 €143.43 €110,439
25. Jul 19 Sell Franklin Resources, Inc. Company 24. Jul 19 24. Jul 19 -28,630 €144.85 €-4,146,985
25. Jul 19 Buy T. Rowe Price Group, Inc. Company 24. Jul 19 24. Jul 19 16 €145.15 €2,322
25. Jul 19 Sell BlackRock, Inc. Company 24. Jul 19 24. Jul 19 -7,055 €144.87 €-1,021,586
25. Jul 19 Buy BlackRock, Inc. Company 24. Jul 19 24. Jul 19 1,651 €145.29 €238,737
25. Jul 19 Sell Legg Mason, Inc. Company 24. Jul 19 24. Jul 19 -29 €144.86 €-4,201
25. Jul 19 Buy Legg Mason, Inc. Company 24. Jul 19 24. Jul 19 31 €144.88 €4,491
25. Jul 19 Sell Citadel Advisors, LLC Company 24. Jul 19 24. Jul 19 -69,964 €145.29 €-10,164,881
25. Jul 19 Buy Citadel Advisors, LLC Company 24. Jul 19 24. Jul 19 77,155 €145.31 €11,211,027
25. Jul 19 Sell Northern Trust Global Investments Company 24. Jul 19 24. Jul 19 -125 €145.10 €-18,137
25. Jul 19 Buy Northern Trust Global Investments Company 24. Jul 19 24. Jul 19 2,614 €144.96 €378,936
25. Jul 19 Sell FMR LLC Company 24. Jul 19 24. Jul 19 -33 €144.95 €-4,783
25. Jul 19 Buy FMR LLC Company 24. Jul 19 24. Jul 19 1,759 €144.92 €254,913
25. Jul 19 Sell Wellington Management Group LLP Company 24. Jul 19 24. Jul 19 -831,413 €145.30 €-120,437,628
25. Jul 19 Buy Wellington Management Group LLP Company 24. Jul 19 24. Jul 19 22,918 €145.30 €3,329,862
24. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 23. Jul 19 23. Jul 19 524,290 €146.10 €76,596,290
24. Jul 19 Sell BlackRock, Inc. Company 23. Jul 19 23. Jul 19 -139 €145.12 €-20,171
24. Jul 19 Buy BlackRock, Inc. Company 23. Jul 19 23. Jul 19 4,796 €145.92 €696,124
24. Jul 19 Sell Citadel Advisors, LLC Company 23. Jul 19 23. Jul 19 -128,178 €146.12 €-18,729,647
24. Jul 19 Buy Citadel Advisors, LLC Company 23. Jul 19 23. Jul 19 145,221 €146.20 €21,231,723
24. Jul 19 Sell FMR LLC Company 23. Jul 19 23. Jul 19 -8,032 €146.08 €-1,171,017
24. Jul 19 Buy FMR LLC Company 23. Jul 19 23. Jul 19 11,396 €145.98 €1,661,606
24. Jul 19 Sell Legg Mason, Inc. Company 23. Jul 19 23. Jul 19 -267 €146.02 €-38,908
24. Jul 19 Sell Franklin Resources, Inc. Company 23. Jul 19 23. Jul 19 -359 €145.92 €-52,380
24. Jul 19 Sell Wellington Management Group LLP Company 23. Jul 19 23. Jul 19 -803,157 €145.83 €-116,882,157
24. Jul 19 Buy Wellington Management Group LLP Company 23. Jul 19 23. Jul 19 22,812 €145.78 €3,325,568
23. Jul 19 Sell T. Rowe Price Group, Inc. Company 22. Jul 19 22. Jul 19 -755 €145.23 €-109,650
23. Jul 19 Buy T. Rowe Price Group, Inc. Company 22. Jul 19 22. Jul 19 381 €145.56 €55,457
23. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 22. Jul 19 22. Jul 19 -198,512 €145.55 €-28,893,281
23. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 22. Jul 19 22. Jul 19 415,886 €145.76 €60,620,875
23. Jul 19 Sell FMR LLC Company 22. Jul 19 22. Jul 19 -10,284 €145.65 €-1,495,867
23. Jul 19 Buy FMR LLC Company 22. Jul 19 22. Jul 19 9,287 €145.34 €1,349,656
23. Jul 19 Sell BlackRock, Inc. Company 22. Jul 19 22. Jul 19 -274 €144.95 €-39,717
23. Jul 19 Buy BlackRock, Inc. Company 22. Jul 19 22. Jul 19 5,715 €145.42 €828,455
23. Jul 19 Sell Citadel Advisors, LLC Company 22. Jul 19 22. Jul 19 -140,068 €145.70 €-17,190,597
23. Jul 19 Buy Citadel Advisors, LLC Company 22. Jul 19 22. Jul 19 137,432 €145.71 €17,190,597
23. Jul 19 Sell Northern Trust Global Investments Company 22. Jul 19 22. Jul 19 -23 €145.41 €-3,344
23. Jul 19 Buy Northern Trust Global Investments Company 22. Jul 19 22. Jul 19 11,201 €145.32 €1,627,702
23. Jul 19 Sell Franklin Resources, Inc. Company 22. Jul 19 22. Jul 19 -700 €145.07 €-101,548
23. Jul 19 Buy Franklin Resources, Inc. Company 22. Jul 19 22. Jul 19 15 €145.27 €2,179
23. Jul 19 Sell Wellington Management Group LLP Company 22. Jul 19 22. Jul 19 -53,333 €145.27 €-7,742,909
22. Jul 19 Sell BlackRock, Inc. Company 19. Jul 19 19. Jul 19 -7,449 €145.41 €-1,082,401
22. Jul 19 Buy BlackRock, Inc. Company 19. Jul 19 19. Jul 19 1,605 €145.41 €233,322
22. Jul 19 Sell FMR LLC Company 19. Jul 19 19. Jul 19 -115,095 €145.11 €-16,694,400
22. Jul 19 Buy FMR LLC Company 19. Jul 19 19. Jul 19 9,523 €144.97 €1,380,039
22. Jul 19 Sell Northern Trust Global Investments Company 19. Jul 19 19. Jul 19 -1,454 €145.41 €-211,424
22. Jul 19 Buy Northern Trust Global Investments Company 19. Jul 19 19. Jul 19 1,569 €145.41 €0
22. Jul 19 Sell Citadel Advisors, LLC Company 19. Jul 19 19. Jul 19 -28,939 €145.43 €-4,208,483
22. Jul 19 Buy Citadel Advisors, LLC Company 19. Jul 19 19. Jul 19 27,512 €145.43 €4,000,961
22. Jul 19 Sell T. Rowe Price Group, Inc. Company 19. Jul 19 19. Jul 19 -5 €144.93 €-725
22. Jul 19 Buy T. Rowe Price Group, Inc. Company 19. Jul 19 19. Jul 19 54 €145.17 €7,837
22. Jul 19 Buy Franklin Resources, Inc. Company 19. Jul 19 19. Jul 19 15 €145.02 €2,175
22. Jul 19 Sell Legg Mason, Inc. Company 19. Jul 19 19. Jul 19 -187 €144.72 €-27,063
22. Jul 19 Buy Legg Mason, Inc. Company 19. Jul 19 19. Jul 19 6,026 €145.00 €873,759
22. Jul 19 Sell Longview Partners (Guernsey) Ltd Company 19. Jul 19 19. Jul 19 -1,500 €145.41 €-218,112
22. Jul 19 Sell Wellington Management Group LLP Company 19. Jul 19 19. Jul 19 -161,268 €145.41 €-23,404,440
22. Jul 19 Buy Wellington Management Group LLP Company 19. Jul 19 19. Jul 19 1,032 €145.41 €150,061
22. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 18. Jul 19 18. Jul 19 337,670 €145.36 €49,083,962
19. Jul 19 Sell BlackRock, Inc. Company 18. Jul 19 18. Jul 19 -450 €144.35 €-64,959
19. Jul 19 Buy BlackRock, Inc. Company 18. Jul 19 18. Jul 19 5,924 €145.15 €855,232
19. Jul 19 Sell FMR LLC Company 18. Jul 19 18. Jul 19 -4,254 €145.01 €-614,155
19. Jul 19 Buy FMR LLC Company 18. Jul 19 18. Jul 19 15,206 €145.23 €2,204,841
19. Jul 19 Sell Citadel Advisors, LLC Company 18. Jul 19 18. Jul 19 -42,102 €145.44 €-6,123,353
19. Jul 19 Buy Citadel Advisors, LLC Company 18. Jul 19 18. Jul 19 46,316 €145.50 €6,739,130
19. Jul 19 Buy Northern Trust Global Investments Company 18. Jul 19 18. Jul 19 6,727 €144.83 €974,275
19. Jul 19 Sell Legg Mason, Inc. Company 18. Jul 19 18. Jul 19 -36 €144.93 €-5,218
19. Jul 19 Buy Legg Mason, Inc. Company 18. Jul 19 18. Jul 19 392 €144.66 €56,706
19. Jul 19 Sell T. Rowe Price Group, Inc. Company 18. Jul 19 18. Jul 19 -20,700 €145.10 €-3,003,509
19. Jul 19 Buy T. Rowe Price Group, Inc. Company 18. Jul 19 18. Jul 19 121 €144.73 €17,512
19. Jul 19 Sell Franklin Resources, Inc. Company 18. Jul 19 18. Jul 19 -508 €144.76 €-73,389
19. Jul 19 Sell Wellington Management Group LLP Company 18. Jul 19 18. Jul 19 -363,785 €145.19 €-52,635,916
19. Jul 19 Sell Longview Partners (Guernsey) Ltd Company 18. Jul 19 18. Jul 19 -110 €144.35 €-15,879
17. Jul 19 Sell BlackRock, Inc. Company 16. Jul 19 16. Jul 19 -2,695 €146.99 €-396,044
17. Jul 19 Buy BlackRock, Inc. Company 16. Jul 19 16. Jul 19 9,469 €147.10 €1,387,235
18. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 17. Jul 19 17. Jul 19 -39,891 €146.49 €-5,843,660
18. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 17. Jul 19 17. Jul 19 45,638 €146.84 €6,701,399
17. Jul 19 Sell Citadel Advisors, LLC Company 16. Jul 19 16. Jul 19 -50,049 €148.12 €-7,413,333
17. Jul 19 Buy Citadel Advisors, LLC Company 16. Jul 19 16. Jul 19 41,504 €148.17 €6,149,485
18. Jul 19 Sell Citadel Advisors, LLC Company 17. Jul 19 17. Jul 19 -54,519 €146.83 €-8,004,983
18. Jul 19 Buy Citadel Advisors, LLC Company 17. Jul 19 17. Jul 19 36,288 €146.83 €5,328,139
18. Jul 19 Sell FMR LLC Company 17. Jul 19 17. Jul 19 -114,715 €146.76 €-16,761,688
18. Jul 19 Buy FMR LLC Company 17. Jul 19 17. Jul 19 9,006 €146.45 €667,305
18. Jul 19 Sell BlackRock, Inc. Company 17. Jul 19 17. Jul 19 -10,277 €146.00 €-1,490,336
18. Jul 19 Buy BlackRock, Inc. Company 17. Jul 19 17. Jul 19 2,480 €146.35 €360,460
18. Jul 19 Sell Legg Mason, Inc. Company 17. Jul 19 17. Jul 19 -83 €145.99 €-12,117
18. Jul 19 Buy Legg Mason, Inc. Company 17. Jul 19 17. Jul 19 40 €146.04 €5,841
18. Jul 19 Sell Wellington Management Group LLP Company 17. Jul 19 17. Jul 19 -233,131 €146.44 €-34,082,952
18. Jul 19 Sell Northern Trust Global Investments Company 17. Jul 19 17. Jul 19 -8 €146.34 €-1,171
18. Jul 19 Buy Northern Trust Global Investments Company 17. Jul 19 17. Jul 19 11,743 €146.81 €1,724,006
18. Jul 19 Sell Franklin Resources, Inc. Company 17. Jul 19 17. Jul 19 -26,500 €146.22 €-3,874,921
18. Jul 19 Buy Franklin Resources, Inc. Company 17. Jul 19 17. Jul 19 5 €144.74 €724
18. Jul 19 Sell T. Rowe Price Group, Inc. Company 17. Jul 19 17. Jul 19 -691 €146.47 €-101,206
18. Jul 19 Buy T. Rowe Price Group, Inc. Company 17. Jul 19 17. Jul 19 22 €146.63 €3,226
18. Jul 19 Sell GIC Pte. Ltd. Company 17. Jul 19 17. Jul 19 -17,045 €144.74 €-2,467,019
17. Jul 19 Sell FMR LLC Company 16. Jul 19 16. Jul 19 -158,501 €147.91 €-23,246,469
17. Jul 19 Buy FMR LLC Company 16. Jul 19 16. Jul 19 5,451 €147.93 €806,262
17. Jul 19 Sell Legg Mason, Inc. Company 16. Jul 19 16. Jul 19 -26,811 €146.89 €-3,936,923
17. Jul 19 Buy Legg Mason, Inc. Company 16. Jul 19 16. Jul 19 41 €146.99 €6,027
17. Jul 19 Sell Franklin Resources, Inc. Company 16. Jul 19 16. Jul 19 -23,220 €146.59 €-3,403,772
17. Jul 19 Sell Northern Trust Global Investments Company 16. Jul 19 16. Jul 19 -83 €147.25 €-12,222
17. Jul 19 Buy Northern Trust Global Investments Company 16. Jul 19 16. Jul 19 11,683 €146.93 €1,716,545
17. Jul 19 Sell T. Rowe Price Group, Inc. Company 16. Jul 19 16. Jul 19 -19,900 €147.83 €-2,940,837
17. Jul 19 Buy T. Rowe Price Group, Inc. Company 16. Jul 19 16. Jul 19 61 €146.98 €8,966
17. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 16. Jul 19 16. Jul 19 101,051 €148.01 €14,956,114
17. Jul 19 Sell Wellington Management Group LLP Company 16. Jul 19 16. Jul 19 -246,379 €147.23 €-36,264,145
17. Jul 19 Buy Wellington Management Group LLP Company 16. Jul 19 16. Jul 19 21,791 €146.45 €3,191,384
17. Jul 19 Buy GIC Pte. Ltd. Company 16. Jul 19 16. Jul 19 150,000 €146.45 €21,968,132
16. Jul 19 Sell Wellington Management Group LLP Company 15. Jul 19 15. Jul 19 -1,430,051 €147.74 €-211,277,930
16. Jul 19 Sell FMR LLC Company 15. Jul 19 15. Jul 19 -71,779 €148.35 €-10,629,187
16. Jul 19 Buy FMR LLC Company 15. Jul 19 15. Jul 19 8,774 €148.12 €1,299,374
16. Jul 19 Sell Citadel Advisors, LLC Company 15. Jul 19 15. Jul 19 -37,481 €148.38 €-5,561,452
16. Jul 19 Buy Citadel Advisors, LLC Company 15. Jul 19 15. Jul 19 38,256 €148.41 €5,677,467
16. Jul 19 Sell BlackRock, Inc. Company 15. Jul 19 15. Jul 19 -2,588 €147.55 €-381,848
16. Jul 19 Buy BlackRock, Inc. Company 15. Jul 19 15. Jul 19 588 €147.55 €86,757
16. Jul 19 Sell Franklin Resources, Inc. Company 15. Jul 19 15. Jul 19 -8 €147.77 €-1,182
16. Jul 19 Sell T. Rowe Price Group, Inc. Company 15. Jul 19 15. Jul 19 -58,200 €147.55 €-8,587,198
16. Jul 19 Sell Northern Trust Global Investments Company 15. Jul 19 15. Jul 19 -589 €147.55 €-86,904
16. Jul 19 Buy Northern Trust Global Investments Company 15. Jul 19 15. Jul 19 5,762 €148.36 €0
16. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 15. Jul 19 15. Jul 19 -435,290 €148.35 €-64,576,976
16. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 15. Jul 19 15. Jul 19 422,599 €148.14 €62,604,112
16. Jul 19 Sell GIC Pte. Ltd. Company 15. Jul 19 15. Jul 19 -101,563 €148.14 €-15,045,614
16. Jul 19 Buy GIC Pte. Ltd. Company 15. Jul 19 15. Jul 19 114 €147.15 €16,775
15. Jul 19 Sell FMR LLC Company 12. Jul 19 12. Jul 19 -334,685 €147.05 €-49,155,013
15. Jul 19 Buy FMR LLC Company 12. Jul 19 12. Jul 19 13,734 €147.23 €2,016,673
15. Jul 19 Sell BlackRock, Inc. Company 12. Jul 19 12. Jul 19 -8,905 €147.32 €-1,307,059
15. Jul 19 Buy BlackRock, Inc. Company 12. Jul 19 12. Jul 19 1,388 €147.32 €204,234
15. Jul 19 Sell Legg Mason, Inc. Company 12. Jul 19 12. Jul 19 -34 €147.23 €-5,006
15. Jul 19 Buy Legg Mason, Inc. Company 12. Jul 19 12. Jul 19 23 €146.87 €3,378
15. Jul 19 Sell Northern Trust Global Investments Company 12. Jul 19 12. Jul 19 -430 €147.11 €-63,258
15. Jul 19 Buy Northern Trust Global Investments Company 12. Jul 19 12. Jul 19 1,154 €147.32 €169,775
15. Jul 19 Sell Citadel Advisors, LLC Company 12. Jul 19 12. Jul 19 -41,223 €147.44 €-6,077,921
15. Jul 19 Buy Citadel Advisors, LLC Company 12. Jul 19 12. Jul 19 96,178 €147.65 €14,200,992
15. Jul 19 Sell T. Rowe Price Group, Inc. Company 12. Jul 19 12. Jul 19 -165 €147.32 €-24,268
15. Jul 19 Buy T. Rowe Price Group, Inc. Company 12. Jul 19 12. Jul 19 33,620 €147.20 €4,940,558
15. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 12. Jul 19 12. Jul 19 -114,083 €147.43 €-16,819,388
15. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 12. Jul 19 12. Jul 19 237,887 €147.52 €35,093,086
15. Jul 19 Sell Franklin Resources, Inc. Company 12. Jul 19 12. Jul 19 -1 €147.32 €-147
15. Jul 19 Sell Wellington Management Group LLP Company 12. Jul 19 12. Jul 19 -528,169 €147.32 €-77,556,847
11. Jul 19 Sell Citadel Advisors, LLC Company 10. Jul 19 10. Jul 19 -58,186 €148.55 €-8,643,765
11. Jul 19 Buy Citadel Advisors, LLC Company 10. Jul 19 10. Jul 19 160,003 €148.64 €23,783,312
12. Jul 19 Sell Citadel Advisors, LLC Company 11. Jul 19 11. Jul 19 -34,354 €148.53 €-5,102,762
12. Jul 19 Buy Citadel Advisors, LLC Company 11. Jul 19 11. Jul 19 44,273 €148.35 €6,567,821
12. Jul 19 Sell BlackRock, Inc. Company 11. Jul 19 11. Jul 19 -1,787 €147.58 €-263,413
12. Jul 19 Buy BlackRock, Inc. Company 11. Jul 19 11. Jul 19 969 €147.69 €142,890
12. Jul 19 Sell FMR LLC Company 11. Jul 19 11. Jul 19 -224,407 €148.14 €-33,123,340
12. Jul 19 Buy FMR LLC Company 11. Jul 19 11. Jul 19 18,634 €148.29 €2,752,493
12. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 11. Jul 19 11. Jul 19 -17,712 €148.02 €-2,621,724
12. Jul 19 Sell Northern Trust Global Investments Company 11. Jul 19 11. Jul 19 -95 €147.79 €-14,040
12. Jul 19 Buy Northern Trust Global Investments Company 11. Jul 19 11. Jul 19 4,144 €147.61 €611,700
12. Jul 19 Sell Legg Mason, Inc. Company 11. Jul 19 11. Jul 19 -37 €147.63 €-5,462
12. Jul 19 Buy Legg Mason, Inc. Company 11. Jul 19 11. Jul 19 109 €147.41 €16,067
12. Jul 19 Sell Franklin Resources, Inc. Company 11. Jul 19 11. Jul 19 -4 €147.40 €-590
12. Jul 19 Sell Wellington Management Group LLP Company 11. Jul 19 11. Jul 19 -192 €147.50 €-28,306
12. Jul 19 Buy Wellington Management Group LLP Company 11. Jul 19 11. Jul 19 2,901 €147.36 €427,504
12. Jul 19 Buy T. Rowe Price Group, Inc. Company 11. Jul 19 11. Jul 19 102 €148.12 €15,108
12. Jul 19 Buy Longview Partners (Guernsey) Ltd Company 11. Jul 19 11. Jul 19 500 €147.40 €73,699
12. Jul 19 Sell GIC Pte. Ltd. Company 11. Jul 19 11. Jul 19 -231,564 €148.18 €-34,301,610
11. Jul 19 Sell Northern Trust Global Investments Company 10. Jul 19 10. Jul 19 -26 €148.18 €-3,853
11. Jul 19 Buy Northern Trust Global Investments Company 10. Jul 19 10. Jul 19 122 €148.43 €18,100
11. Jul 19 Sell Wellington Management Group LLP Company 09. Jul 19 09. Jul 19 -26,441 €148.94 €-3,934,959
11. Jul 19 Buy Wellington Management Group LLP Company 09. Jul 19 09. Jul 19 13,561 €148.79 €2,017,690
11. Jul 19 Sell Citadel Advisors, LLC Company 09. Jul 19 09. Jul 19 -43,680 €149.54 €-6,531,932
11. Jul 19 Buy Citadel Advisors, LLC Company 09. Jul 19 09. Jul 19 57,920 €149.42 €8,654,670
11. Jul 19 Sell FMR LLC Company 10. Jul 19 10. Jul 19 -44 €148.37 €-6,527
11. Jul 19 Buy FMR LLC Company 10. Jul 19 10. Jul 19 206,371 €148.53 €30,609,575
11. Jul 19 Sell BlackRock, Inc. Company 10. Jul 19 10. Jul 19 -10,197 €148.35 €-1,512,550
11. Jul 19 Buy BlackRock, Inc. Company 10. Jul 19 10. Jul 19 4,230 €148.20 €626,728
11. Jul 19 Sell Legg Mason, Inc. Company 10. Jul 19 10. Jul 19 -2 €148.62 €-297
11. Jul 19 Buy Legg Mason, Inc. Company 10. Jul 19 10. Jul 19 210 €148.27 €31,137
11. Jul 19 Sell Citadel Advisors, LLC Company 08. Jul 19 08. Jul 19 -93,756 €149.49 €-14,015,913
11. Jul 19 Buy Citadel Advisors, LLC Company 08. Jul 19 08. Jul 19 378,299 €149.53 €56,566,737
11. Jul 19 Sell Franklin Resources, Inc. Company 10. Jul 19 10. Jul 19 -20 €148.42 €-2,968
11. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 10. Jul 19 10. Jul 19 -30,735 €148.46 €-4,562,803
11. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 10. Jul 19 10. Jul 19 208,461 €148.69 €30,995,514
11. Jul 19 Sell GIC Pte. Ltd. Company 10. Jul 19 10. Jul 19 -400,182 €148.36 €-59,370,400
10. Jul 19 Sell Northern Trust Global Investments Company 09. Jul 19 09. Jul 19 -249 €149.34 €-37,187
10. Jul 19 Buy Northern Trust Global Investments Company 09. Jul 19 09. Jul 19 3,189 €149.37 €476,344
10. Jul 19 Sell Legg Mason, Inc. Company 09. Jul 19 09. Jul 19 -10 €148.79 €-1,488
10. Jul 19 Buy Legg Mason, Inc. Company 09. Jul 19 09. Jul 19 66 €149.37 €9,858
10. Jul 19 Sell BlackRock, Inc. Company 09. Jul 19 09. Jul 19 -2,487 €148.52 €-369,378
10. Jul 19 Buy BlackRock, Inc. Company 09. Jul 19 09. Jul 19 15,920 €149.24 €2,370,608
10. Jul 19 Sell FMR LLC Company 09. Jul 19 09. Jul 19 -155,209 €149.26 €-23,101,584
10. Jul 19 Buy FMR LLC Company 09. Jul 19 09. Jul 19 5,204 €149.24 €776,630
10. Jul 19 Sell T. Rowe Price Group, Inc. Company 09. Jul 19 09. Jul 19 -2,711 €149.27 €-403,127
10. Jul 19 Buy Franklin Resources, Inc. Company 09. Jul 19 09. Jul 19 110 €148.61 €16,347
10. Jul 19 Sell GIC Pte. Ltd. Company 09. Jul 19 09. Jul 19 -290,031 €149.01 €-43,218,708
10. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 09. Jul 19 09. Jul 19 293,375 €149.53 €43,868,843
10. Jul 19 Buy Longview Partners (Guernsey) Ltd Company 09. Jul 19 09. Jul 19 10,100 €148.52 €1,500,086
09. Jul 19 Sell GIC Pte. Ltd. Company 08. Jul 19 08. Jul 19 -249,398 €147.93 €-36,893,735
09. Jul 19 Sell Wellington Management Group LLP Company 08. Jul 19 08. Jul 19 -5,905 €147.64 €-871,663
09. Jul 19 Sell FMR LLC Company 08. Jul 19 08. Jul 19 -245,575 €149.17 €-36,282,850
09. Jul 19 Buy FMR LLC Company 08. Jul 19 08. Jul 19 11,576 €149.30 €1,715,297
09. Jul 19 Sell Legg Mason, Inc. Company 08. Jul 19 08. Jul 19 -75,378 €148.51 €-11,194,585
09. Jul 19 Buy Legg Mason, Inc. Company 08. Jul 19 08. Jul 19 70 €148.16 €10,371
09. Jul 19 Sell BlackRock, Inc. Company 08. Jul 19 08. Jul 19 -967 €147.09 €-142,232
09. Jul 19 Buy BlackRock, Inc. Company 08. Jul 19 08. Jul 19 1,225 €149.48 €180,362
09. Jul 19 Sell Northern Trust Global Investments Company 08. Jul 19 08. Jul 19 -14,349 €147.59 €-2,117,701
09. Jul 19 Buy Northern Trust Global Investments Company 08. Jul 19 08. Jul 19 6,379 €147.83 €943,039
09. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 08. Jul 19 08. Jul 19 -59,525 €149.17 €-8,879,493
09. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 08. Jul 19 08. Jul 19 86,415 €149.50 €12,919,252
09. Jul 19 Sell Franklin Resources, Inc. Company 08. Jul 19 08. Jul 19 -14,630 €148.03 €-2,163,227
09. Jul 19 Buy Franklin Resources, Inc. Company 08. Jul 19 08. Jul 19 349,105 €148.21 €51,661,479
09. Jul 19 Buy T. Rowe Price Group, Inc. Company 08. Jul 19 08. Jul 19 740 €148.40 €109,820
08. Jul 19 Sell Legg Mason, Inc. Company 05. Jul 19 05. Jul 19 -9 €150.28 €-1,352
08. Jul 19 Buy Legg Mason, Inc. Company 05. Jul 19 05. Jul 19 2 €150.37 €301
08. Jul 19 Sell BlackRock, Inc. Company 05. Jul 19 05. Jul 19 -474 €149.56 €-70,893
08. Jul 19 Buy BlackRock, Inc. Company 05. Jul 19 05. Jul 19 3,532 €149.56 €528,255
08. Jul 19 Sell FMR LLC Company 05. Jul 19 05. Jul 19 -59,715 €150.65 €-8,931,757
08. Jul 19 Buy FMR LLC Company 05. Jul 19 05. Jul 19 18,001 €150.76 €2,708,759
08. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 05. Jul 19 05. Jul 19 162,578 €150.66 €24,493,961
08. Jul 19 Buy T. Rowe Price Group, Inc. Company 05. Jul 19 05. Jul 19 61 €150.80 €9,199
08. Jul 19 Buy Franklin Resources, Inc. Company 05. Jul 19 05. Jul 19 179,301 €150.55 €26,994,253
08. Jul 19 Sell GIC Pte. Ltd. Company 05. Jul 19 05. Jul 19 -420,541 €150.78 €-63,261,500
08. Jul 19 Buy Longview Partners (Guernsey) Ltd Company 05. Jul 19 05. Jul 19 3,500 €149.56 €523,469
08. Jul 19 Sell Wellington Management Group LLP Company 05. Jul 19 05. Jul 19 -689 €150.73 €-103,801
05. Jul 19 Buy Franklin Resources, Inc. Company 03. Jul 19 03. Jul 19 250,000 €150.15 €37,532,637
04. Jul 19 Sell FMR LLC Company 03. Jul 19 03. Jul 19 -242 €150.16 €-36,338
04. Jul 19 Buy FMR LLC Company 03. Jul 19 03. Jul 19 2,686 €150.17 €403,365
04. Jul 19 Sell Legg Mason, Inc. Company 03. Jul 19 03. Jul 19 -43 €150.18 €-6,458
04. Jul 19 Buy Legg Mason, Inc. Company 03. Jul 19 03. Jul 19 998 €150.26 €149,961
04. Jul 19 Sell Northern Trust Global Investments Company 02. Jul 19 02. Jul 19 -875 €150.08 €-131,318
04. Jul 19 Buy Northern Trust Global Investments Company 02. Jul 19 02. Jul 19 1,786 €150.12 €268,118
04. Jul 19 Sell BlackRock, Inc. Company 03. Jul 19 03. Jul 19 -12,025 €150.36 €-1,807,642
04. Jul 19 Buy BlackRock, Inc. Company 03. Jul 19 03. Jul 19 1,085 €150.36 €163,140
04. Jul 19 Sell T. Rowe Price Group, Inc. Company 03. Jul 19 03. Jul 19 -20,600 €150.23 €-3,094,680
04. Jul 19 Buy T. Rowe Price Group, Inc. Company 03. Jul 19 03. Jul 19 616 €150.01 €92,406
04. Jul 19 Sell Wellington Management Group LLP Company 03. Jul 19 03. Jul 19 -125,730 €150.36 €-18,900,315
04. Jul 19 Sell GIC Pte. Ltd. Company 03. Jul 19 03. Jul 19 -408,837 €150.28 €-61,421,814
04. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 03. Jul 19 03. Jul 19 46,494 €150.47 €6,995,750
03. Jul 19 Sell T. Rowe Price Group, Inc. Company 02. Jul 19 02. Jul 19 -300 €149.14 €-44,742
03. Jul 19 Buy T. Rowe Price Group, Inc. Company 02. Jul 19 02. Jul 19 621,332 €150.45 €93,221,072
03. Jul 19 Sell Franklin Resources, Inc. Company 02. Jul 19 02. Jul 19 -1,684 €150.06 €-250,966
03. Jul 19 Buy Franklin Resources, Inc. Company 02. Jul 19 02. Jul 19 152,869 €149.95 €22,841,909
03. Jul 19 Sell BlackRock, Inc. Company 02. Jul 19 02. Jul 19 -2,327 €150.06 €-349,189
03. Jul 19 Buy BlackRock, Inc. Company 02. Jul 19 02. Jul 19 10,504 €150.06 €1,573,131
03. Jul 19 Sell Northern Trust Global Investments Company 02. Jul 19 02. Jul 19 -1,458 €150.06 €-218,787
03. Jul 19 Buy Northern Trust Global Investments Company 02. Jul 19 02. Jul 19 1,947 €150.31 €292,649
03. Jul 19 Sell FMR LLC Company 02. Jul 19 02. Jul 19 -59 €148.85 €-8,773
03. Jul 19 Buy FMR LLC Company 02. Jul 19 02. Jul 19 104,748 €150.05 €15,563,848
03. Jul 19 Sell Wellington Management Group LLP Company 02. Jul 19 02. Jul 19 -50,899 €150.25 €-7,548,477
03. Jul 19 Buy Wellington Management Group LLP Company 02. Jul 19 02. Jul 19 27,900 €150.06 €4,164,127
03. Jul 19 Sell Legg Mason, Inc. Company 02. Jul 19 02. Jul 19 -1 €149.90 €-150
03. Jul 19 Buy Legg Mason, Inc. Company 02. Jul 19 02. Jul 19 3 €149.94 €450
03. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 02. Jul 19 02. Jul 19 40,708 €150.58 €6,129,714
03. Jul 19 Sell GIC Pte. Ltd. Company 02. Jul 19 02. Jul 19 -265,546 €150.52 €-39,792,815
02. Jul 19 Sell FMR LLC Company 01. Jul 19 01. Jul 19 -329 €148.61 €-48,816
02. Jul 19 Buy FMR LLC Company 01. Jul 19 01. Jul 19 14,051 €148.85 €2,079,946
02. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 01. Jul 19 01. Jul 19 -69,602 €148.74 €-10,352,848
02. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 01. Jul 19 01. Jul 19 338,332 €149.01 €50,414,405
02. Jul 19 Sell Wellington Management Group LLP Company 01. Jul 19 01. Jul 19 -555,153 €148.45 €-82,210,422
02. Jul 19 Sell Northern Trust Global Investments Company 01. Jul 19 01. Jul 19 -8,819 €148.48 €-1,309,431
02. Jul 19 Buy Northern Trust Global Investments Company 01. Jul 19 01. Jul 19 5,351 €148.47 €794,461
02. Jul 19 Sell BlackRock, Inc. Company 01. Jul 19 01. Jul 19 -62,208 €148.22 €-9,186,205
02. Jul 19 Buy BlackRock, Inc. Company 01. Jul 19 01. Jul 19 4,417 €148.28 €653,910
02. Jul 19 Sell Legg Mason, Inc. Company 01. Jul 19 01. Jul 19 -80,006 €147.97 €-11,838,151
02. Jul 19 Buy Legg Mason, Inc. Company 01. Jul 19 01. Jul 19 2 €148.08 €296
02. Jul 19 Sell Franklin Resources, Inc. Company 01. Jul 19 01. Jul 19 -2,175 €148.47 €-322,921
02. Jul 19 Buy Franklin Resources, Inc. Company 01. Jul 19 01. Jul 19 50,115 €148.46 €7,424,643
02. Jul 19 Sell GIC Pte. Ltd. Company 01. Jul 19 01. Jul 19 -253,964 €148.45 €-37,640,784
02. Jul 19 Sell Longview Partners (Guernsey) Ltd Company 01. Jul 19 01. Jul 19 -6,400 €148.05 €-947,547
02. Jul 19 Buy Longview Partners (Guernsey) Ltd Company 01. Jul 19 01. Jul 19 6,800 €148.05 €1,006,768
01. Jul 19 Sell Legg Mason, Inc. Company 28. Jun 19 28. Jun 19 -80,000 €147.23 €-11,778,732
01. Jul 19 Sell FMR LLC Company 28. Jun 19 28. Jun 19 -535,454 €147.14 €-78,707,175
01. Jul 19 Buy FMR LLC Company 28. Jun 19 28. Jun 19 59,360 €147.59 €8,730,033
01. Jul 19 Buy Northern Trust Global Investments Company 28. Jun 19 28. Jun 19 3,593 €147.19 €528,854
01. Jul 19 Sell BlackRock, Inc. Company 28. Jun 19 28. Jun 19 -258,627 €147.51 €-38,054,586
01. Jul 19 Buy BlackRock, Inc. Company 28. Jun 19 28. Jun 19 41,746 €147.17 €6,142,574
01. Jul 19 Sell Franklin Resources, Inc. Company 28. Jun 19 28. Jun 19 -1,100 €146.84 €-161,523
01. Jul 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 28. Jun 19 28. Jun 19 -385,835 €147.49 €-56,906,420
01. Jul 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 28. Jun 19 28. Jun 19 697,219 €147.76 €103,022,078
01. Jul 19 Sell Wellington Management Group LLP Company 28. Jun 19 28. Jun 19 -77,515 €147.14 €-3,614,016
01. Jul 19 Sell GIC Pte. Ltd. Company 28. Jun 19 28. Jun 19 -204,252 €147.30 €-30,037,538
01. Jul 19 Buy GIC Pte. Ltd. Company 28. Jun 19 28. Jun 19 146 €147.12 €21,479
28. Jun 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 27. Jun 19 27. Jun 19 100,976 €147.27 €14,870,707
28. Jun 19 Sell Legg Mason, Inc. Company 27. Jun 19 27. Jun 19 -55 €146.47 €-8,056
28. Jun 19 Buy Legg Mason, Inc. Company 27. Jun 19 27. Jun 19 421 €146.37 €61,623
28. Jun 19 Sell BlackRock, Inc. Company 27. Jun 19 27. Jun 19 -1,769 €146.06 €-258,372
28. Jun 19 Buy BlackRock, Inc. Company 27. Jun 19 27. Jun 19 2,585 €146.10 €377,609
28. Jun 19 Sell FMR LLC Company 27. Jun 19 27. Jun 19 -131,505 €147.15 €-19,289,379
28. Jun 19 Buy FMR LLC Company 27. Jun 19 27. Jun 19 107,602 €146.70 €15,763,879
28. Jun 19 Sell Columbia Management Investment Advisers, LLC Company 27. Jun 19 27. Jun 19 -28 €146.06 €-4,090
28. Jun 19 Buy Columbia Management Investment Advisers, LLC Company 27. Jun 19 27. Jun 19 75 €146.06 €10,954
28. Jun 19 Sell Franklin Resources, Inc. Company 27. Jun 19 27. Jun 19 -5,186 €146.46 €-759,518
28. Jun 19 Sell Wellington Management Group LLP Company 27. Jun 19 27. Jun 19 -17,694 €146.75 €-2,590,339
28. Jun 19 Buy Wellington Management Group LLP Company 27. Jun 19 27. Jun 19 25,946 €146.83 €3,809,683
28. Jun 19 Sell GIC Pte. Ltd. Company 27. Jun 19 27. Jun 19 -304,808 €146.47 €-44,644,552
27. Jun 19 Sell FMR LLC Company 26. Jun 19 26. Jun 19 -1,147,433 €145.01 €-165,913,519
27. Jun 19 Buy FMR LLC Company 26. Jun 19 26. Jun 19 5,497 €144.71 €795,199
27. Jun 19 Sell Legg Mason, Inc. Company 26. Jun 19 26. Jun 19 -425 €144.54 €-61,428
27. Jun 19 Buy Legg Mason, Inc. Company 26. Jun 19 26. Jun 19 350 €144.66 €50,631
27. Jun 19 Sell Columbia Management Investment Advisers, LLC Company 26. Jun 19 26. Jun 19 -23,672 €144.13 €-3,411,297
27. Jun 19 Buy Columbia Management Investment Advisers, LLC Company 26. Jun 19 26. Jun 19 3,772 €144.11 €543,571
27. Jun 19 Sell BlackRock, Inc. Company 26. Jun 19 26. Jun 19 -104,799 €144.74 €-15,157,589
27. Jun 19 Buy BlackRock, Inc. Company 26. Jun 19 26. Jun 19 38,025 €144.69 €5,488,832
27. Jun 19 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 26. Jun 19 26. Jun 19 -929,383 €145.10 €-134,853,223
27. Jun 19 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 26. Jun 19 26. Jun 19 664,120 €145.08 €96,351,962
27. Jun 19 Buy Franklin Resources, Inc. Company 26. Jun 19 26. Jun 19 150 €144.38 €21,657
27. Jun 19 Sell GIC Pte. Ltd. Company 26. Jun 19 26. Jun 19 -53,070 €144.96 €-7,693,205
27. Jun 19 Sell Wellington Management Group LLP Company 26. Jun 19 26. Jun 19 -10,321 €144.72 €-1,493,686
27. Jun 19 Buy Wellington Management Group LLP Company 26. Jun 19 26. Jun 19 3,655 €143.97 €526,196
26. Jun 19 Sell Columbia Management Investment Advisers, LLC Company 25. Jun 19 25. Jun 19 -300,947 €142.70 €-42,938,738
26. Jun 19 Buy Columbia Management Investment Advisers, LLC Company 25. Jun 19 25. Jun 19 15,626 €142.68 €2,229,494
26. Jun 19 Sell Franklin Resources, Inc. Company 25. Jun 19 25. Jun 19 -62,900 €143.51 €-9,026,967
26. Jun 19 Sell BlackRock, Inc. Company 25. Jun 19 25. Jun 19 -946,003 €145.02 €-136,494,132
26. Jun 19 Buy BlackRock, Inc. Company 25. Jun 19 25. Jun 19 75,000 €146.25 €10,811,484
26. Jun 19 Sell Wellington Management Group LLP Company 25. Jun 19 25. Jun 19 -1,207,252 €147.90 €-174,237,293
26. Jun 19 Buy Wellington Management Group LLP Company 25. Jun 19 25. Jun 19 1,659 €113.81 €188,818
26. Jun 19 Sell GIC Pte. Ltd. Company 25. Jun 19 25. Jun 19 -416,612 €144.29 €-59,994,198
07. Mar 19 Buy Brenton Saunders Individual 07. Mar 19 07. Mar 19 1,760 €128.60 €225,246
20. Nov 18 Buy Matthew Walsh Individual 16. Nov 18 16. Nov 18 1,000 €137.67 €137,673
07. Sep 18 Buy Christopher Coughlin Individual 06. Sep 18 06. Sep 18 10,000 €164.14 €1,641,024
04. Sep 18 Sell Nesli Basgoz Individual 30. Aug 18 30. Aug 18 -1,055 €163.18 €-172,152
04. Sep 18 Buy Joseph Boccuzi Individual 30. Aug 18 30. Aug 18 900 €163.64 €147,277
04. Sep 18 Buy Thomas Freyman Individual 30. Aug 18 30. Aug 18 1,100 €163.73 €180,099
X
Management checks
We assess Allergan's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Allergan has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women’s health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.

Details
Name: Allergan plc
A60
Exchange: DB
Founded: 1983
$46,217,712,758
328,032,715
Website: http://www.allergan.com
Address: Allergan plc
Clonshaugh Business and Technology Park,
Coolock,
Dublin,
Co. Dublin, D17 E400,
Ireland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE AGN Common Stock New York Stock Exchange US USD 17. Feb 1993
DB A60 Common Stock Deutsche Boerse AG DE EUR 17. Feb 1993
LSE 0Y7T Common Stock London Stock Exchange GB USD 17. Feb 1993
BMV AGN N Common Stock Bolsa Mexicana de Valores MX MXN 17. Feb 1993
BASE AGN CEDEAR EACH 8 REP 1 COM USD0.0001 Buenos Aires Stock Exchange AR ARS 12. Apr 2019
Number of employees
Current staff
Staff numbers
16,900
Allergan employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/08/16 21:50
End of day share price update: 2019/08/16 00:00
Last estimates confirmation: 2019/08/15
Last earnings filing: 2019/08/08
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.